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Abstract
Background: Motor imagery (MI) is increasingly used in neurorehabilitation to facilitate motor performance. Our
previous study results demonstrated significantly improved walking after rhythmic-cued MI in people with multiple
sclerosis (pwMS). The present feasibility study was aimed to obtain preliminary information of changes in walking,
fatigue, quality of life (QoL) and MI ability following cued and non-cued MI in pwMS. The study further investigated
the feasibility of a larger study and examined the reliability of a two-dimensional gait analysis system.
Methods: At the MS-Clinic, Department of Neurology, Medical University of Innsbruck, Austria, 15 adult pwMS (1.5–4.5
on the Expanded Disability Status Scale, 13 females) were randomised to one of three groups: 24 sessions of 17 min of
MI with music and verbal cueing (MVMI), with music alone (MMI), or non-cued (MI). Descriptive statistics were reported
for all outcomes. Primary outcomes were walking speed (Timed 25-Foot Walk) and walking distance (6-Minute Walk
Test). Secondary outcomes were recruitment rate, retention, adherence, acceptability, adverse events, MI ability
(Kinaesthetic and Visual Imagery Questionnaire, Time-Dependent MI test), fatigue (Modified Fatigue Impact Scale) and
QoL (Multiple Sclerosis Impact Scale-29). The reliability of a gait analysis system used to assess gait synchronisation with
music beat was tested.
Results: Participants showed adequate MI abilities. Post-intervention, improvements in walking speed, walking distance,
fatigue, QoL and MI ability were observed in all groups. Success of the feasibility criteria was demonstrated by recruitment
and retention rates of 8.6% (95% confidence interval, CI 5.2, 13.8%) and 100% (95% CI 76.4, 100%), which exceeded the
target rates of 5.7% and 80%. Additionally, the 83% (95% CI 0.42, 0.99) adherence rate surpassed the 67% target rate. Intra-
rater reliability analysis of the gait measurement instruments demonstrated excellent Intra-Class Correlation coefficients for
step length of 0.978 (95% CI 0.973, 0.982) and step time of 0.880 (95% CI 0.855, 0.902).
Conclusion: Results from our study suggest that cued and non-cued MI are valuable interventions in pwMS who were
able to imagine movements. A larger study appears feasible, however, substantial improvements to the methods are
required such as stratified randomisation using a computer-generated sequence and blinding of the assessors.
Trial registration: ISRCTN ISRCTN92351899. Registered 10 December 2015.
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Background
Introduction
Multiple Sclerosis (MS) is a chronic disease of the
central nervous system, which leads to destruction of
the protective myelin nerve sheaths and accumulating
disability. People with MS have impairment in motor,
sensory, visual and other body systems [1]. Evidence
shows that 40–80% of patients report fatigue [2, 3]
which, together with walking impairment, contributes to
a limitation in their walking endurance [4] and
independence in daily life activities [5]. Therefore, it is
considered essential to develop novel rehabilitation stra-
tegies to improve walking and fatigue, which negatively
impact walking abilities.
Motor imagery
Apart from physical training, motor imagery (MI) has
increasingly been used in neurorehabilitation to enhance
motor relearning in people with neurological disorders
[6]. Defined as mental rehearsal of a movement, the
motor action is not executed [7, 8]. Motor areas of the
brain responsible for movements’ physical execution are
activated, although to a lesser degree, during imagined
movements [6–9]. Both real and imagined movements
are associated with similar motor preparation processes
[7, 8]. In addition, imagined and actual movements have
previously been shown to share similar temporal profiles
[8, 10]. Mental chronometry, that is temporal con-
gruence, is the similar time duration of imagined and
real motor actions [10, 11]. Consequently, the capacity
to preserve the temporal features of a movement during
MI has been associated with a person’s MI ability [11,
12]. Mental chronometry studies showed that the MI ac-
curacy and its temporal organisation were impaired in
participants with MS versus controls; these deficits in
MI ability were associated with cognitive impairment,
but were independent from motor functioning [13–16].
Reduced MI accuracy and timing are also related to de-
pression [14]. However, rhythmic auditory cueing has
been found to promote the MI ability in people with
MS, by optimising their MI duration and movement
amplitudes during an upper limb task [17].
Rationale
To our knowledge, only one study explored the effects of
rhythmic-cued MI in 15 people with stroke [18]. Kim et
al. observed an improvement in walking performance after
kinaesthetic rhythmic-cued MI practice, compared to vis-
ual MI practice without auditory cueing [18]. Similarly, re-
sults from our previous study showed significant
improvements in walking performance after four weeks of
music- and metronome-cued kinaesthetic MI practice
with additional verbal cueing in people with MS and mild
to moderate disability [19]. Music-cued MI was more
effective than metronome-cued MI in improving fatigue
and quality of life (QoL). However, we did not measure
the participants’ ability to imagine movements or their ac-
tual gait synchronisation with music beat. We also did not
include a non-cued MI group and thus could not compare
between the effects of cued and non-cued MI. In other
words, there are various areas of uncertainty in knowledge
concerning the mechanisms of the rhythmic-cueing and
MI interventions in persons with MS, which have not yet
been addressed. For example, the contributions from the
MI practice and the music and verbal cueing, respectively,
to the functional improvements have not been investi-
gated. To our knowledge, only one study explored the ef-
fect of five weeks of MI practice on fatigue, walking speed
and QoL in 20 people with MS and mild to moderate
disability [20]. Their findings showed that fatigue and QoL
significantly improved, but the walking speed improve-
ment was not significant.
Rhythmic auditory stimulation has been successfully
used to improve walking performance [21]. Hence, we
hypothesised that rhythmic auditory cueing of the MI
would serve as an external timekeeper to the imagined
steps. Thereby, like in real walking [22], imagery of walk-
ing along a regular and hence predictable auditory
rhythm might be processed quite accurately, mainly
because the imagined steps are produced slightly ahead
of the cue [21]. This coupling process between external
rhythm and body adjustment is referred to as rhythmic
entrainment which, for example, causes the synchronisa-
tion of gait with the tempo of music beat [21, 22].
Against the background of these findings, we suggested
that rhythmic cueing might induce entrainment and en-
hance the MI ability in our participants. To the best of
our knowledge so far, no study has evaluated the mecha-
nisms of differently cued and non-cued MI for walking
rehabilitation in people with MS. Thus, we plan to con-
duct a randomised controlled trial (RCT) to investigate
the effects and mechanisms of differently cued and non-
cued MI on walking, fatigue, QoL, MI ability and gait
synchronisation with music beat in people with MS. The
present feasibility study was used to gather preliminary
results and examine the feasibility of the aforesaid RCT.
Aims
The aims of this feasibility study were:
1) to explore the success of the feasibility criteria:
recruitment and retention rates and adherence rate;
2) to explore the safety of the interventions, adverse
events and participant acceptability of the
interventions;
3) to obtain preliminary information on change in
walking speed and walking distance induced by the
two types of music-cued and non-cued MI;
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4) to acquire preliminary information on change in
fatigue produced by the two types of music-cued
and non-cued MI;
5) to collect preliminary data on the change in QoL
generated by the two types of music-cued and non-
cued MI;
6) to evaluate the baseline MI ability and obtain
preliminary information on its change;
7) to assess the reliability and repeatability of the
quantitative gait measurement instruments used to
assess synchronisation with music beat.
Methods
Study design and location
A three-group parallel randomised controlled single-
centre feasibility trial was conducted. The adjunct CON-
SORT checklist for pilot and feasibility studies is available
as Additional file 1 [23]. All measurements were taken at
the MS Clinic of the Clinical Department of Neurology,
Medical University of Innsbruck, Austria.
Participants and recruitment
Recruitment used unselected consecutive sampling and
restricted randomisation from 3rd March to 14th April
2016. Due to the piloting character of this study and
time constraints, 15 participants were recruited into
three groups. The MS-Clinic currently cares for approxi-
mately 2500 people with MS, 339 were screened during
recruitment, of those 174 were eligible. A CONSORT
flow diagram for pilot and feasibility studies [23] is
shown in Fig. 1.
Inclusion Criteria were: people with any MS phenotype
according to McDonald’s criteria [24], mild to moderate
disability (Expanded Disability Status Scale, EDSS 1.5 to
4.5) [25], aged 18 years or over, any ethnicity, German
speaking (questionnaires, MI familiarisation, instructions).
Exclusion Criteria were: concomitant diseases which
may affect rhythmic cued MI or walking (e.g. orthopaedic
disorders, untreated hearing loss), a relapse of MS within
the last three months, recent start of physiotherapy treat-
ment or change of medication which is known to affect
walking within the last two months, known pregnancy,
overt symptoms or signs of depression or cognitive dys-
function diagnosed and documented by the Innsbruck MS
Clinic. A relapse during the intervention period would
have led to the exclusion from the study.
Eligible individuals were identified during their usual
visit to the Outpatient MS Clinic by their neurologist
(TB). After that, they received the recruitment flyer from
the reception staff. They also obtained the participant
information sheet and detailed verbal information on the
study from the researcher who is a physiotherapist (BS).
Oral and written information was presented in com-
prehensible lay language. Eligible individuals had the
opportunity to ask questions. They had at least twenty-
four hours to consider their participation and to consult
family members or others. After one week, potential par-
ticipants who agreed to telephone contact, were called
by the researcher asking if they would like to participate
in the study. Written informed consent was obtained by
the researcher. Participants were then randomly allo-
cated using a 1:1:1 ratio, and they were asked to draw a
sealed envelope, prepared by a researcher not involved
in this study, with numbers ´1′, ´2′ or ´3′ which corre-
sponded with the three study groups. The randomisation
was restricted insofar as only 15 envelopes were pro-
vided. Using this procedure, the physiotherapist involved
in the recruitment could not influence group allocation.
Intervention
The intervention of this study consisted of music- and
verbally-cued MI (MVMI group), music-cued MI (MMI
group) and non-cued MI (MI group). After the rando-
misation and prior to the intervention, study participants
were familiarised with rhythmic-cued MI or non-cued
MI by the researcher (BS), as suggested in previous stu-
dies [26, 27]. These authors have proposed the PET-
TLEP approach to MI in neurorehabilitation, involving
the “Physical, Environmental, Task, Timing, Learning,
Emotional, and Perspective” components of MI [28].
The PETTLEP checklist is based on neuroscientific fin-
dings and has been developed by Holmes and Collins
(2001, page 60) for performance improvements in
athletes. The PETTLEP elements concern the physical,
or bodily, position of the practitioner including arousal,
the imagined environment, the imagined task, the MI
timing, the learning or changes induced by the MI, the
emotions or affective states, which are related to the MI
task, and the MI perspective. The PETTLEP ideas were
applied to the context of the present study to enhance
the effectiveness of the intervention.
Firstly, participants were informed about the concept
of (cued) MI and its application in sports and neuroreh-
abilitation. Secondly, participants also learned about the
different perspectives (internal and external) and modes
(visual, kinaesthetic) which can be adopted during MI
[29, 30]. In the visual mode, the persons imagine
watching themselves (internal perspective) or other
people (external perspective) moving, and in the kinaes-
thetic mode, the persons experience or feel themselves
moving [31]. When employed in clinical practice, people
use both perspectives when asked to imagine a move-
ment. Therefore, participants had the opportunity to try
them out for themselves and become aware of their
preferred mode or perspective. The researcher placed
emphasis on internal, kinaesthetic MI, which was
adopted for the intervention and MI assessment of this
study and the internal, visual MI which was only used
Seebacher et al. Archives of Physiotherapy  (2018) 8:6 Page 3 of 19
for the MI ability testing. During the training, partici-
pants were asked for MI content characteristics such as
the mode and perspective they were using, for the envi-
ronment or for movement aspects they were imagining
(learning). Moreover, the duration of the actual and
imagined walking performance was compared to moni-
tor the mental process [26]. Participants were asked to
walk a six-metre distance along the marked hallway
while the time was measured. After that, they were
asked to imagine themselves walking the same six-metre
distance they had reached and indicate when they imag-
ined reaching the same point. The time was measured,
and feedback was given to the participants. If desired,
they could repeat the imaginative task as many times as
they wanted. The intervention is presented in Table 1
and was based on the Template for Intervention
Description and Replication (TIDieR template) [32].
Selection of the music style, beat patterns and tempo
were based on relevant literature in the field [21]. Music
beat in the MVMI and MMI groups was in 2/4 or 4/4 m
Fig. 1 CONSORT flow diagram for pilot and feasibility studies
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Table 1 Intervention chart
ITEM NO ITEM DESCRIPTION
1 BRIEF NAME MVMI Group MMI Group MI Group
Music- and verbally cued MI Music-cued MI Non-cued MI
2 WHY PETTLEP approach to MI (Holmes and Collins 2001)
3 WHAT
MATERIALS
- Study CDs or dropbox link including the audio mix and download to smartphone, laptop, tablet or MP3-player
- 4 sessions on each CD, one for each week
- Headphones or earphones could be used if desired
Study CD
Content
- Kinaesthetic MI instructions - Kinaesthetic MI instructions - Kinaesthetic MI instructions
- Instrumental music in 2/4 or 4/4 m - Instrumental music in 2/4 or 4/
4 m
- Emphasis of every first beat, or every first and third
beat by rhythmic verbal cues (e.g. “toe-off” or “step-
step”)
For example, music titles used in week two were: Unheilig, Der Berg (Intro), 82 bpm; Black,
Wonderful Life, 106 bpm; Malcolm Arnold, The River Kwai March, 120 bpm; Uriah Heep,
Lady in black, 86 bpm; Abba, Dancing queen, 101 bpm; Toto, Africa, 100 bpm; DJ Bobo, I’m
living to love you, 110 bpm; Katy Perry, Firework, 120 bpm.
No cueing
Availability
of CDs
After completion of the main study, a download of the 3 study CDs will be available upon request from the corresponding
author.
4 WHAT
PROCEDURES
- MI introduction, familiarisation and training: in lay language; description of the concept of MI; its application and effects
in sports and neurorehabilitation; principles of neuroplasticity; MI perspectives (internal and external) and modes
(visual, kinaesthetic).
- Measurement of actual and imagined walking duration over a 6-m distance to monitor the mental process
- Performance feedback for participants and repeated training if desired
- Weekly phone calls for support and adherence reports
- Additional introduction to rhythmic auditory stimulation plus its use in
neurorehabilitation
- Rhythmic-cued MI familiarisation
PETTLEP
Elements
Position
(Physical)
- Practise at any time of the day when alert
- Seated in an upright body position
- Shoulders relaxed
- Avoid tightening the muscles or moving
- Eyes closed
- Normal breathing
Environment - Practice in a quiet place at home
- Imagine walking indoors (long hallway similar to that in the MS Clinic) and walking outdoors (on a straight and familiar path)
Tasks - Take long strides
- Take giant strides
- Roll your feet on the ground and feel your body weight on your soles
- Touch the ground with your heels first
- Raise the front of your feet
- Raise your knees
- Pace
- Place/feel your weight on your feet
- Place/feel your weight on your legs
- Stamp your feet while walking
- Walk effortlessly, almost as if you were floating
- Walk forcefully and energetically as if you were an athlete
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and in addition, in the MVMI group, every first beat, or
every first and third beat were stressed and emphasised
by rhythmic verbal cues [21, 22]. Appropriate rhythmical
sequences were cut and mixed (GarageBand, Apple Inc.)
with the MI instructions of walking. Karaoke music
pieces were selected from a wide range of musical styles,
including rock, pop, folk music, dance, techno and
marching music, hard rock and film music.
Participants were asked to practice MI six times a
week, once a day for seventeen minutes over a four week
period. After each week and in all groups, the audio mix
was changed to facilitate adherence and to retain atten-
tion with the MI [21], so that four mixes, designed in
the same way, were on one CD. Participants were called
weekly to support them with the MI and as a reminder
of the practice. The phone calls were made by the re-
searcher, who introduced the participants to the (cued)
MI practice and explained all the procedures. Questions
that were asked during the phone calls are added as
Additional file 2.
Data collection
Demographic (gender, age) and MS disease specific data
(current EDSS) were extracted from patients’ charts,
study specific assessment data were collected pre and
post intervention by one physiotherapist who is not a
member of the MS Clinic. The German version of all
assessments was used. Baseline and post-intervention
Table 1 Intervention chart (Continued)
ITEM NO ITEM DESCRIPTION
- March as if you were in the army
- Walk in an extremely upright posture such as when balancing a sachet, filled with rice, on your head
- Feel the swinging of your arms while walking
- Feel the swinging of your legs while walking
Timing External timing was provided: “imagine yourself
walking in time with the music and verbal cues”
External timing was provided:
“imagine yourself walking in time
with the music”
Timing was internal and depended on
the tempo and intensity of the
walking tasks.
- Tempo (cadence) was between 80 and 120 steps/min
- Slow, medium and fast music pieces alternated, with a general progression in the tempo
- The imagined walking tempo was consistent with the music beat at 80–120 bpm.
Learning - See familiarisation
- Additionally, weekly phone call support was provided
Emotion MI instructions included motivational and arousal enhancing aspects (e.g. walk forcefully and energetically as if you were an
athlete). See instructions under Tasks.
Motivational instrumental music was used with the MI
Perspective Kinaesthetic MI from an internal, first-person perspective
5 WHO
PROVIDED
The intervention including the preparation of the CDs was provided by the researcher (BS), an experienced physiotherapist with
11 years of musical training.
6 HOW - MI introduction, familiarisation and training: individually or in small groups (2–3 participants) and depending on the group
they were allocated to
- Monitoring of mental process: individually
- Weekly phone calls: individually
7 WHERE - MI introduction, familiarisation, training and monitoring of mental process: at MS Clinic Innsbruck, Department of Physiotherapy
- Cued MI practice: At participants’ homes MI practice: At participants’ homes
8 WHEN AND
HOW MUCH
17 min, 6 times a week, for 4 weeks
9 TAILORING Same intervention for all participants Same intervention for all
participants
Same intervention for all participants
10
MODIFICATIONS
No modifications No modifications No modifications
11 HOW WELL
PLANNED
- Intervention adherence was assessed using a participant diary and also during weekly phone calls and at post-intervention
- Recording in excel sheets was performed by the researcher (physiotherapist) who instructed participants
12 HOW WELL
ACTUAL
The adherence rate was median 5 (range 4, 6) times per week or 83% (95% confidence interval 0.42, 0.99).
Abbreviations: MI: motor imagery; bpm: beats per minute
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assessments were performed at the physiotherapy de-
partment of the MS Clinic, always in the mid-afternoon,
in view of daytime fluctuations in walking abilities and
fatigue. Participants were allowed to rest at any time
during the instructions and assessments. A history of de-
pression and cognitive dysfunction before onset or its
worsening or new occurrence after diagnosis of MS was
rigorously asked and documented by the same treating
neurologist (TB). Clinical definitions of depression and
cognitive dysfunction were used rather than formal
neuropsychological testing. Depression was defined as a
state of low mood and loss of activity along with charac-
teristic symptoms such as sadness, anxiety, awkward-
ness, loss of appetite, insomnia, up to suicidal thoughts.
Cognitive dysfunction was defined by report and clinical
assessment of characteristic symptoms such as impair-
ment in orientation, memory, attention, learning,
language, visuospatial skills, calculating, planning or any
other executive function.
Primary outcomes
Feasibility
Feasibility of conducting a full-scale RCT was evaluated.
The criteria for feasibility success were: a) a target re-
cruitment rate of 5.7% out of 174 eligible patients (or 10
participants per month), b) a target retention rate of
80% and c) a target minimum adherence rate of 67% (4
practice sessions per week out of a maximum of 6).
Safety, adverse events and acceptability
Participants were asked to report any adverse event such
as falls, excessive fatigue, psychological distress and/or
other safety related occurrences. Severe adverse events
would have led to early study termination. During the
weekly phone calls, participants were asked for their
feedback on the study procedures, which were recorded
in Excel files and reported. Participant adherence with
the interventions was noted by participants in a diary.
Adherence and the acceptability of the interventions
were reported narratively. Acceptability referred to
kinaesthetic MI, melodies, beat tempo and the verbal
cueing. Questions that were asked by the researcher are
available as additional information; see Additional file 2.
Secondary outcomes
Walking speed and walking distance
Walking speed was assessed by the Timed 25-Foot Walk
(T25FW) [33]. The T25FW is the most commonly re-
ported short walking test, which has excellent validity,
reliability and responsiveness in people with MS [34]
and was administered according to instructions in the
Multiple Sclerosis Functional Composite [35]. There is a
consensus in the literature that a change of 20% and
above in walking speed corresponds to a clinically
meaningful change, or minimal clinically important dif-
ference (MCID), in walking [36].
Walking distance was measured by the 6-Minute Walk
Test (6MWT) [37]. The 6MWT was carried out as
recommended by the American Thoracic Society-
Guidelines. Learmonth et al. (2013) demonstrated that a
change of 20% and above in walking distance represents
the minimal detectable change (MDC) [38], reflecting
the smallest real difference which exceeds the measure-
ment error [39, 40]. Other research reported that a
change in walking distance of 20% and above is clinically
meaningful [41]. Based on clinical judgement, a 20%
change in walking distance is relevant for the patients in
their daily lives. Good to excellent psychometric proper-
ties of the 6MWT have been demonstrated in an MS
population [37]. 6MWT reference values for healthy
women and men aged 20 to 50 are mean (standard
deviation, SD) 593 ± 57 m and 638 ± 44 m, respectively,
with differences depending on height and age [42].
Females and males with MS and an EDSS below 4.0
walked mean (SD) 380.1 ± 156.0 m and 459.5 ± 133.8 m,
respectively; women and men with an EDSS of up to 6.5
walked 322.2 ± 156.4 m and 362.8 ± 169.2 m, with varia-
tions connected to age, cardiorespiratory function and
balance [43].
Walking aids for both the T25FW and 6MWT were
used if required and were documented and kept consis-
tent during the two assessments.
Fatigue
Fatigue was assessed using the Modified Fatigue Impact
Scale (MFIS). The MFIS is a modified version of the
Fatigue Impact Scale [44] and one part of the Multiple
Sclerosis Quality of Life Inventory (MSQLI) [45]. It is a
21 item Likert scale that evaluates, via self-report, the ef-
fects of fatigue on physical, cognitive and psychosocial
functioning, with higher numbers indicating greater
fatigue. All items can be answered by five categories
(never, rarely, sometimes, often and almost always; range
0–4) resulting in a total score from 0 to 84. The MFIS
has an excellent reliability and moderate to high validity
and responsiveness in people with MS [46, 47]. Based on
previous studies, the cut-off value for MS-related fatigue
was set at ≥38 points on the MFIS total score [48].
Responsiveness of the MFIS, as expressed by the
smallest detectable change (SDC) is − 16.2 points on the
total score, − 8.9 points on the physical subscale, − 8.0
points on the cognitive subscale and − 2.3 points on the
psychosocial subscale [47].
Quality of life
QoL was assessed with the Multiple Sclerosis Impact Scale
(MSIS-29). The MSIS-29 is a 29-item disease-specific,
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patient-reported questionnaire for measuring the impact
of MS on individual lives, with 20 items associated with a
physical subscale and 9 items with a psychological sub-
scale [49]. Responses use a 5-point Likert scale, ranging
from (1) “not at all” to (5) “extremely”. The MSIS-29
showed the strongest psychometric properties compared
to other QoL scales [50, 51]. The items ask about the
impact of MS on day-to-day living over the past two
weeks, higher scores indicating a greater impact of MS on
daily function. According to a Rasch analysis, the two
scales are different and should not be combined to a total
score [52]; in the current study, the analysis was
performed accordingly.
Motor imagery ability
Evidence has recommended to comprehensively assess the
MI ability using at least two different approaches because
some people may have problems generating vivid images
and intense sensations and/or subjectively assessing their
MI ability, and others with the duration of their mental
imagery, in relation to real movements [53, 54]. In other
words, both questionnaire and mental chronometry (that
is, temporal congruence) tests are required to assess the
MI capability and both were used in this study.
The Kinaesthetic and Visual Imagery Questionnaire
(KVIQ-10) is the short version of the KVIQ-20, which is
a MI ability questionnaire developed for people with
physical disabilities [55, 56]. Thus, the questionnaire is
researcher-administered, and the movements are easily
performed while participants are seated [55, 56]. The
KVIQ-10 consists of a visual (V) and kinaesthetic (K)
subscale and assesses the clarity of the image (V) and
the intensity of the sensations (K) on a five-point ordinal
scale [55]. The five visual categories range from (1) “no
image” to (5) “image as clear as seeing”; the five
kinaesthetic categories range from (1) “no sensation” to
(5) “as intense as executing the action”. The maximum
KVIQ-10 total scale is 50 points, with 25 points in each
subscale, and higher scores representing higher levels of
MI ability. The KVIQ-10 has been attributed excellent
validity and reliability in people with stroke [55] and MS
[57]. For this study, the validated German version of the
KVIQ-10 was used, the KVIQ-G-10 [56]. The minimum
expected level of the MI ability at baseline and post-
intervention, as assessed by the KVIQ-G-10, was median
3 out of 5 points on both subscales [58].
The Time-Dependent MI (TDMI) screening test is a
mental chronometry test which measures the number of
imagined stepping movements in seated participants
over 3 time periods (15, 25 and 45 s) [53]. Good to ex-
cellent reliability of the TDMI was shown in people with
stroke with intra-class correlation coefficients (ICCs) be-
tween 0.87 and 0.93 [12].To encourage kinaesthetic MI
from a first-person perspective, participants were asked
to close their eyes and feel themselves moving their right
or left leg to a board placed in front of their feet.
Repeatability and reliability of gait analysis instruments
Participants were asked to synchronise their steps with
instrumental music in regular metre at 110 bpm. The
choice of the music beat frequency of 110 bpm was
based on the gait literature in people with MS [59–61].
People with mild to moderate MS showed a mean (SD)
cadence of 109.1 ± 23.3 steps/min [59]; patients with MS
and higher disability levels walked mean 98.97 ± 19.95
steps/min [60]. The cadence in pwMS with an EDSS of
up to 5.7 was between 100.0 ± 23.3 steps/min and 112.1
± 11.3 steps/min [61]. The music was played with an
Apple i-phone and X-Mi X Mini II Capsule-
Loudspeakers in a calm hallway free from obstacles. Gait
synchronisation analysis with musical pulse requires
knowing step lengths and step times, therefore, 2-
dimensional (2D) video recording in the frontal plane
was performed [62, 63]. The videos were taken with a
Panasonic HC-WX979 4 K camcorder with a frame rate
of 50 fields per second, which was mounted on a 1.3 m
high Haehnel 9,994,180 Triad 40 Lite Tripod placed 5 m
from the participant [62, 64]. Participants walked be-
tween two marked lines, 1 m apart, on a 30 m hallway,
so that they could accelerate and decelerate their speed,
and adjust their gait to the music beat. Thus, only the
central 4.5 m were video-recorded while the participant
walked 4 to 6 times back and forth, depending on their
step length (Fig. 2). Participants were allowed to wear
shoes or walk barefoot and the type of footwear or its
absence was to be kept consistent during all trials. This
procedure enabled the acquisition of 25–35 steps per
participant. These video footages were used to measure
the average step length and step time per participant
(test measures). The video-footage was analysed using
CCC Utilius Fairplay 5 Software. This software allowed
calibration of the field of view, in order to reduce paral-
lax error [64]. Step length was defined as the distance
between the initial contact of one foot with the floor,
followed by the opposite foot, and was measured in me-
tres [64]. Step time was defined as the period between
the initial contact of one foot and the other foot, and
was measured in seconds [64]. In other words, the
crucial moment was the heel contact with the ground,
or, in the case of severe spasticity, the toe contact. Excel-
lent image exposure was achieved, due to the camcorder
4 K technology and a well-lit hallway, therefore, no
reflective markers were used.
Prior to the study, the accuracy of the video analysis
software calibration grid was evaluated, by using a 7 × 1
metres large grid mat with 0.2 × 0.2 m large grid fields
which accurately covered the marked walkway (Fig. 3).
Accuracy was confirmed, as the grid fields of the grid mat
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and the video calibration grid were congruent. Moreover,
the measurement technique described above was esta-
blished in 13 healthy team colleagues. After that, this feasi-
bility study assessed the repeatability and reliability of the
gait analysis system. In addition to the test measures
described above, the step lengths and step times were mea-
sured 4 times on the video footage by the same rater, using
Utilius Fairplay 5 software. From each of these measures
the mean step length and step time was calculated, so that
4 retest measures were available.
Statistical analysis
All statistics were performed using IBM SPSS software,
release 24.0 (IBM Corporation, Armonk, NY, USA) and
GraphPad Prism 6 (GraphPad, San Diego, California,
USA). Intention-to-treat analysis was performed for all
cases, which were analysed by the originally assigned
groups. Descriptive statistics were reported for all out-
comes. Medians (interquartile ranges) were reported for
continuous and ordinal data: fatigue, QoL, KVIQ-G-10
MI ability (all: 5 categories), TDMI MI ability, walking
speed and walking distance; medians (range) were
reported for age, compliance (7 categories: 0–6 times
per week), and disability (EDSS). Means (95% CI) were
reported for reliability data, and raw count (frequency,
percentage) for nominal data (recruitment rates, reten-
tion rate, missing data, falls and adverse events). Median
MI vividness scores were calculated by dividing the me-
dian KVIQ-G-10 scores by the number of items, that is,
5 for the visual/kinaesthetic subscales, and 10 for the
total score. Spearman’s correlation coefficients (median
with interquartile ranges; all baseline pairwise corre-
lations) were calculated for the numbers of imagined
stepping movements over 15, 25 and 45 s (TDMI). Dif-
ferences between the three groups at the baseline were
examined using Fisher’s Exact test (nominal data: gender;
walking aid use and fatigue yes/no) and Kruskal Wallis
test (continuous data: age; walking speed and walking dis-
tance; ordinal data: fatigue, QoL, MI ability). Corrected
Fisher’s exact contingency table analysis was calculated
using an online calculator (http://www.physics.csbsju.edu/
stats/exact_NROW_NCOLUMN_form.html).
The recruitment rate (%) was determined by dividing
the number of participants who consented by the num-
ber of patients eligible, multiplied by 100. The retention
rate was estimated: (N who completed the study/N total
sample)*100, where N is the number of participants. The
adherence rate was reported as the percentage of the
Fig. 2 Representative image of the 2D video-based gait assessment
Fig. 3 Representative image of the accuracy evaluation of the video analysis software calibration
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scheduled (cued) MI practice (6×/week), actually per-
formed by the participants over the 4 week study period
[65]. The eligibility, recruitment and adherence rates
were calculated with their 95% CI according to the
Wilson ‘score’ method cited by Newcombe [66]; when
the proportion was close to 0 or 1, a Poisson approxima-
tion as described by Brown was used [67].
The ICC was estimated as a measure of intra-rater reli-
ability. The ICCs were calculated with their 95% CI using
a two-way mixed model based on absolute agreement with
single measure analysis. Point estimates of the ICC were
rated as excellent (0.9–1), good (0.73–0.9), moderate (0.4–
0.74) and poor (0–0.39) [68]. The standard error of meas-
urement (SEM) was calculated to assess the random error,
or variability, of the step length and step time measure-
ments. It is the difference between an observed score and
its ‘true’ score [69]. The SEM was calculated using the for-
mula: SEM= SD*√(1-ICC), where SD is the sample stand-
ard deviation [70, 71]. The SEM was multiplied by 1.96 in
order to compute the error that is expected in 95% of the
measurements [69]. This value was then multiplied by
√(2) to compute the MDC95, i.e. the smallest amount of
change between two repeated measurements, based on a
95% confidence interval, which is beyond the measure-
ment error and hence is a genuine change [72].
Results
Baseline characteristics
Participants´ baseline data are shown in Table 2 and
Additional file 3. The female-to-male ratio was 6.5:1, as
only two males participated in this study. Participants in
the MI group were younger and walked faster and a lon-
ger distance. In the MI group, one participant used two
walking sticks during all walking tests. Participants in the
MVMI group were more disabled, showed higher fatigue
values, lower QoL and lower kinaesthetic MI ability.
These differences between the groups did not reach statis-
tically significance. Apart from slightly lower values in the
MVMI group, with a 25th percentile of 2.7, participants
seemed to have been able to practice MI, as indicated by
median KVIQ-G-10 vividness scores of 4.0 (interquartile
range 3.2, 4.6) out of 5.0. Additionally, there was a moder-
ate to strong positive mean Spearman’s correlation of r =
0.78 (interquartile range 0.77, 0.84) for the numbers of
imagined stepping movements during 15, 25 and 45 s for
both lower limbs.
Primary outcomes
Feasibility
a) 174 out of 339 people with MS were eligible for the
study, corresponding to an eligibility rate of 51.3%
(95% CI 46.0, 56.6%) (see Fig. 1). Of these 174
participants, 15 consented to the study within one
month, which is a recruitment rate of 8.6% (95% CI
5.2, 13.8%). This recruitment rate exceeded the
target recruitment rate of 5.7%.
b) All 15 participants completed the study and there
were no missing data, both corresponding to a 100%
retention rate (95% CI 76.4, 100%). This retention
rate surpassed the target retention rate of 80%.
c) With reference to a maximum practice frequency of
6 times per week, participants reported to have
practised median 5 (range 4, 6) times per week. This
adherence rate of 83% (95% CI 0.42, 0.99) was
greater than the target adherence rate of 67%.
Safety, adverse events and acceptability
No safety-related events such as falls occurred in this
study. No adverse events related to this home-based
study were reported. Phone calls were considered
supportive by participants. One participant in the MI
group reported minor concentration problems during
the MI which resolved with practice. Overall, partici-
pants in the MI group appeared to be satisfied with
the interventions. All participants in the MVMI and
MMI groups reported that they liked the music styles,
melodies, and tempo changes of the music pieces.
Moreover, 9 out of 15 participants reported as an ad-
junctive comment that they found safe and conveni-
ent practicing the intervention at home, in a sitting
position. To summarise, the interventions were found
to be acceptable or even pleasurable.
Secondary outcomes
Walking speed and walking distance
Change in walking performance between baseline and
post intervention for participants in all groups is
presented in Table 3 and Fig. 4. Improvements in
walking speed and walking distance were observed in
all groups with the greatest walking distance improve-
ments in the cued MI groups. Only one participant
in the MVMI group reached a clinically significant
improvement in walking speed of ≥20%. Three partic-
ipants in the MVMI group and two participants in
both MMI and MI groups showed a clinically mean-
ingful improvement in walking distance of ≥20% from
baseline to post intervention.
Fatigue
As can be seen in Table 3 and Fig. 5 and was consistent
with our previous results, improvement in fatigue was
observed in all groups. At baseline, 6 out of 15 partici-
pants in all groups had fatigue, with ≥38 points on the
MFIS total score, which was reduced to 2 participants in
total from the MVMI group.
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Quality of life
As shown in Table 3 and Fig. 6, QoL improved in all
groups or remained at least stable. Throughout the
study, the lowest QoL values were observed in the
MVMI group.
Motor imagery ability
Post-intervention, as compared to baseline, participants
showed higher MI abilities. The MI ability, as assessed
by median total KVIQ-G-10 scores, reached similar
values in all groups, with 4.6 (interquartile range 4.0 to
4.8) points in the MVMI group, when compared to 4.8
(interquartile range 4.2 to 4.8) points in the MMI group
and 4.2 (interquartile range 4.0 to 4.6) points in the
MI group. Better MI abilities were also suggested by
an overall median KVIQ-G-10 score of 4.0 (interquar-
tile range 4.1 to 4.8) and strongly correlated TDMI
measures of median r = 0.89 (interquartile range 0.84
Table 2 Baseline characteristics
Parameter Group 1 Group 2 Group 3 P-value
Music and verbally cued motor
imagery (MVMI)
Music cued motor imagery (MMI) Motor imagery (MI)
N = 5 N = 5 N = 5
Gendera (F:M) N = 4:1 N = 5:0 N = 4:1 0.999d
Age (years)b 52.0 (41.0, 69.0) 54.0 (34.0, 72.0) 37.0 (27.0, 74) 0.500e
EDSSb 4.5 (2.0–4.5) 2.5 (2.5–4.5) 2.5 (1.5–4.5) 0.387e
Walking aid use during testinga
No/unilateral/bilateral aid N = 5/0/0 N = 5/0/0 N = 4/0/1 0.999d
T25FWc (seconds) 5.6 (5.2, 6.2) 7.0 (5.3, 7.0) 4.9 (4.6, 5.4) 0.264e
6MWTc (metres) 367.5 (348.0, 435.2) 380.6 (337.2, 392.0) 460.5 (442.9, 476.8) 0.249e
MFIS physical subc 21.0 (2.0, 25.0) 12.0 (10.5, 25.0) 16.0 (9.0, 21.0) 0.983e
MFIS cognitive subc 17.0 (11.5, 22.5) 3.0 (0.0, 16.5) 11.0 (11.0, 14.0) 0.098e
MFIS psychosoc subc 2.0 (1.0, 4.0) 2.0 (0.0, 5.0) 3.0 (1.5, 5.0) 0.638e
MFIS total scorec 40.0 (17.5, 51.0) 28.0 (13.0, 39.0) 30.0 (23.5, 38.0) 0.564e
MFIS total score≥ 38 N = 3/2 N = 2/3 N = 1/4 0.800d
MSIS-29 physical subc 45.0 (17.5, 49.4) 20.0 (17.5, 39.4) 16.2 (10.6, 35.6) 0.296e
MSIS-29 psychological subc 27.8 (18.0, 33.3) 11.1 (17.5, 39.4) 11.1 (8.3, 25.0) 0.137e
KVIQ-G-10 visual subc 21.0 (17.5, 23.5) 20.0 (17.5, 24.5) 21.0 (17.5, 24.0) 0.992e
Median visual scorec 4.2 (3.5, 4.7) 4.0 (3.5, 4.9) 4.2 (3.5, 4.8) 0.992e
KVIQ-G-10 kinaesthetic subc 15.0 (13.5, 18.5) 24.0 (15.5, 24.5) 23.0 (18.0, 23.5) 0.189e
Median kinaesthetic scorec 3.0 (2.7, 3.7) 4.8 (3.1, 4.9) 4.6 (3.6, 4.7) 0.189e
KVIQ-G-10 totalc 40.0 (31.0, 40.0) 43.0 (33.5, 49.0) 44.0 (36.0, 47.0) 0.328e
Median total scorec 4.0 (3.1, 4.0) 4.3 (3.3, 4.9) 4.4 (3.6, 4.7) 0.328e
TDMI 25 s rightc 15.0 (12.0, 22.0) 14.0 (12.0, 16.0) 16.0 (11.5, 23.0) 0.688e
TDMI 15 s leftc 10.0 (9.0, 11.5) 9.0 (7.5, 11.0) 13.0 (6.5, 14.5) 0.572e
TDMI 45 s rightc 27.0 (19.5, 36.0) 23.0 (19.0, 31.0) 33.0 (20.0, 38.5) 0.664e
TDMI 15 s left2c 10.0 (8.5, 12.0) 8.0 (8.0, 9.5) 12.0 (7.5, 13.0) 0.231e
TDMI 25 s leftc 16.0 (14.5, 19.5) 16.0 (14.5, 18.0) 20.0 (12.0, 21.0) 0.883e
TDMI Spearman’s rc 0.72 (0.47, 0.82) 0.59 (0.46, 0.72) 0.87 (0.80, 0.97)
Abbreviations: N: Counted number of participants; F:M: Females: Males; EDSS: Expanded Disability Status Scale; MFIS: Modified Fatigue Impact Scale; MFIS physical
sub: MFIS physical subscale; MFIS cognitive sub: MFIS cognitive subscale; MFIS psychosoc sub: MFIS psychosocial subscale; MSIS-29 physical sub: Multiple Sclerosis
Impact Scale-29 physical subscale; MSIS-29 psychological sub: Multiple Sclerosis Impact Scale-29 psychological subscale; KVIQ-G-10: Kinaesthetic and visual imagery
questionnaire, German short version; KVIQ-G-10 visual sub: KVIQ-G-10 visual subscale; KVIQ-G-10 kinaesthetic sub: KVIQ-G-10 kinaesthetic subscale; KVIQ-G-10 total:
KVIQ-G-10 total score; r: Spearman’s correlation coefficient (all pairwise correlations; all significant ≤0.05); TDMI: Time-dependent motor imagery screening test;
T25FW: Timed 25-Foot Walk; 6MWT: 6-Minute Walk Test
aCounted number of participants
bMedian (range)
cMedian (interquartile range)
dAnalysed with corrected Fisher’s Exact contingency table analysis
eAnalysed with Kruskal Wallis test
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to 0.91). Strong correlations of the TDMI measures
were observed in all groups, as presented in Fig. 7.
Reliability of gait analysis instruments
Results from the reliability analysis of the gait analysis
system are shown in Table 4. Excellent intra-rater reli-
ability between measures was found, as evidenced by
ICCs around 0.98 for step length and of 0.88 for step
time. The SEM for repeated measures was 0.013 m and
for step time 0.014 s. In other words, the SEM was small
to moderate for step length measures and small for step
time measures. The MDC95 for step length was 0.037 m
and for step time 0.038 s. This means that only when an
individual’s change from baseline to post-intervention or
follow-up in step length and step time exceeds 3.7 cm or
0.038 s one can be 95% confident that the individual was
actually changed.
Discussion
As far as we know, this study was the first study to
explore the feasibility of the methods to be used for a
full-scale RCT that will investigate the mechanisms and
effects of cued and non-cued MI on walking, fatigue and
QoL in people with MS.
Table 3 Walking, fatigue and quality of life post-intervention data for each study group
Parameter MVMI group MMI group MI group
T25FW (seconds)
Change from baselinea −0.1 (−0.7, −0.1) −0.4 (−0.9, −0.3) −0.4 (− 0.4, − 0.3)
Post-interventiona 5.1 (5.0, 5.5) 6.0 (4.9, 6.0) 5.0 (4.2, 5.1)
Participants with clinically significant
improvement (≥20%)
N = 1/5 N = 0/5 N = 0/5
6MWT (metres)
Change from baselinea 85.5 (59.4, 97.1) 65.1 (39.5, 74.8) 33.6 (11.6, 77.7)
Post-interventiona 453.2 (450.5, 470.0) 418.0 (412.0, 469.0) 476.5 (465.0, 569.3)
Participants with clinically significant
improvement (≥20%)
N = 3/5 N = 2/5 N = 2/5
MFIS physical subscale
Change from baselinea −3.0 (−7.5, 4.0) −2.0 (−13.5, −0.5) −3.0 (−6.5, −1.5)
Post interventiona 14.0 (9.0, 19.5) 9.0 (1.0, 21.5) 12.0 (7.5, 15.0)
MFIS cognitive subscale
Change from baselinea −4.0 (−5.5, 0.5) −3 (−9.5, 0.0) −2.0 (−4.5, −0.5)
Post interventiona 15.0 (10.0, 18.0) 0.0 (0.0, 7.0) 10.0 (6.5, 13.0)
MFIS psychosocial subscale
Change from baselinea 0.0 (−1.0, 0.0) 0.0 (−3.5, 0.0) −2.0 (−2.5, −0.5)
Post interventiona 2.0 (0.5, 3.5) 0.0 (0.0, 2.5) 1.0 (0.0, 3.5)
MFIS total score
Change from baselinea −9.0 (−13.0, 4.5) −6.0 (−23.5, −3.0) −9.0 (− 10.5, −4.5)
Post interventiona 26.0 (22.0, 41.0) 12.0 (2.5, 28.0) 23.0 (15.0, 30.5)
MFIS total score≥ 38 (post-intervention) N = 2/5 N = 0/5 N = 0/5
MSIS-29 physical subscale
Change from baselinea −1.2 (− 11.9, 3.7) −7.5 (− 13.7, − 2.5) − 2.5 (−8.1, 6.2)
Post interventiona 27.5 (18.7, 48.1) 16.2 (8.1, 30.6) 21.2 (10.6, 30.0)
MSIS-29 psychological subscale
Change from baselinea 0.0 (−11.1, 9.7) −5.5 (−6.9, 2.8) −5.5 (−9.7, 1.4)
Post interventiona 30.6 (11.1, 37.5) 5.6 (0.0, 23.6) 8.3 (4.2, 19.4)
Abbreviations: T25FW Timed 25-Foot Walk, 6MWT 6-Minute Walk Test, MFIS Modified Fatigue Impact Scale, MFIS physical MFIS physical subscale, MFIS cognitive
MFIS cognitive subscale, MFIS psychosocial MFIS psychosocial subscale, MFIS total MFIS total score, MSIS-29 =MS Impact Scale-29; N: Counted number
of participants
With walking speed (T25FW), improvement is indicated by a minus and worsening by a plus; with walking distance (6MWT), improvement is indicated by a plus
and worsening by a minus
aMedian (interquartile range)
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Feasibility
The observed recruitment, retention and adherence rates
exceeded the pre-specified target rates so that a larger
study appears feasible. The phone support could have
added to adherence rates of median 5 (range 4–6) out of 6.
We expect a similar adherence rate in the main trial,
mainly because the interventions were acceptable, if not
pleasurable to participants. Nevertheless, we recognise that
even with careful monitoring via phone-calls, participants
could have stated their adherence rates slightly incorrectly.
Safety, adverse events and acceptability
Participants spontaneously reported that they considered
the interventions safe and convenient because they were
allowed to practise the MI at home and in a sitting po-
sition. As there were no falls or adverse events, it seems
safe to continue with the study procedures. 10 out of 10
participants in both music-cued MI groups reported that
they liked the music styles and they regarded the inter-
vention acceptable, with 8 out of 10 participants report-
ing the music intervention as pleasurable. Based on the
high acceptability of the music styles, the same music
will be used in the main study. All participants in the
non-cued MI group were satisfied with the intervention,
and two participants viewed the intervention as pleasur-
able as they appreciated the focus on their body aware-
ness without any distraction. These findings are not
unexpected as the melody and beat of music have been
shown to impact on emotional function, the urge to
move and the perception of fatigue [73]. In addition, we
selected appropriate music pieces following participant
feedback from our previous study, so as to use a higher
amount of music pieces with a faster beat. At first
glance, pure MI practise might be less stimulating than
music-cued MI, however, the repeated attention to-
wards the MI could positively impact on movement
coordination.
We narratively assessed the acceptability of the inter-
ventions in this study as we consider high acceptability
Fig. 4 Walking performance pre- and post-intervention. a Walking Speed. b Walking distance. Medians are shown by lines in the centre of the
box-plots; the interquartile ranges are indicated by the boxes and ranges by the whiskers. Abbreviations: MI group = non-cued motor imagery
group; MMI group = music-cued motor imagery group; MVMI group = music- and verbally cued motor imagery group; T25FW = Timed 25-Foot
Walk; 6MWT = 6-Minute Walk Test. The grey boxes indicate the baseline data and the white boxes present the post-intervention data
Fig. 5 Total fatigue pre- and post-intervention. The red line represents
the cut-off point for fatigue as defined at ≥38 points on the MFIS [48].
Medians are shown by lines in the centre of the box-plots;
the interquartile ranges are indicated by the boxes and ranges by the
whiskers. Abbreviations: MFIS = Modified Fatigue Impact Scale; MI group
= non-cued motor imagery group; MMI group = music-cued motor
imagery group; MVMI group = music- and verbally cued motor imagery
group. The grey boxes indicate the baseline data and the white boxes
present the post-intervention data
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an extremely important fact; as otherwise, no-one would
like to practise nearly every day. In addition, the
motivation and commitment during the home-based
practice would be lower, which might be accompanied
by tiredness, particularly when sitting with closed eyes.
Walking
The preliminary analysis from this study showed an im-
provement in walking speed and walking distance after
both types of cued MI and non-cued MI. Consistent
with our previous results, the greatest improvement in
walking distance was seen after music- and verbally-
cued MI. We suggest that the regular rhythmic cueing,
both by music and verbally, facilitated the brain’s
temporal mechanisms similar to that found during cued
gait training [22]. Rhythmic-cued MI could then have
induced a synchronisation of imagined walking with the
beat [21, 22]. Additionally, repeated rehearsal of imag-
ined walking may have facilitated motor learning in all
groups [54]. Moreover, as demonstrated in the sports
domain and physiotherapy practice, motor tasks need to
be specifically trained, in order to produce relevant im-
provements [74]. The same may apply to MI training,
given the comparable characteristics of executed and
imagined movements and an overlapping brain area
Fig. 6 Quality of life pre- and post-intervention. a Physical quality of life. b Psychological quality of life. Medians are shown by lines in the centre of the
box-plots; the interquartile ranges are indicated by the boxes and ranges by the whiskers. Abbreviations: MI group = non-cued motor imagery group; MMI
group = music-cued motor imagery group; MSIS-29 = Multiple Sclerosis Impact Scale-29 MVMI group = music- and verbally cued motor imagery group
Fig. 7 MI ability pre- and post-intervention. a MI vividness. b Mental
chronometry during MI. Abbreviations: KVIQ-G-10 = Kinaesthetic and
Visual Imagery Questionnaire-10, German short version: Medians are
shown by lines in the centre of the box-plots; the interquartile
ranges are indicated by the boxes and ranges by the whiskers; MI
group = non-cued motor imagery group; MMI group = music-cued
motor imagery group; MVMI group = music- and verbally cued motor
imagery group. The grey boxes indicate the baseline data and the
white boxes present the post-intervention data
Table 4 Repeatability and reliability of gait measurement
instruments
Gait parameters ICC (95% CI) SEM MDC95
Step length 0.978 (0.973, 0.982) 0.013 m 0.037 m
Step time 0.880 (0.855, 0.902) 0.014 s 0.038 s
Abbreviations: SEM standard error of measurement, ICC (95% CI) intraclass-
correlation coefficient (95% confidence interval), MDC95 minimum detectable
change with a 95% confidence interval
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activation during real movement and MI [75]; hence in
the current project, a specific training of imagined walk-
ing was used. Finally, based on the walking improve-
ments we speculate that cued and non-cued MI
rehearsal induced neural plasticity, which could be an
underlying mechanism [76], however, this was outside
the scope of this study.
Fatigue
Post intervention, our preliminary results showed a mild
improvement in fatigue in all groups when compared to
baseline. These findings are in line with results from
Catalan et al. (2011) who found significantly improved
fatigue after non-cued MI practice in people with MS
also at 6 month follow-up [20]. These results also agree
with our previous study in people with mild to moderate
MS where we observed an improvement in fatigue after
rhythmic-cued MI [19].
Quality of life
To evaluate the impact of the two types of music-cued
MI and non-cued MI on the quality of the participants’
day-to-day lives, this study also obtained preliminary
information on MS-related QoL. Improvements in phys-
ical QoL were observed in all groups; surprisingly and
inconsistently with our previous findings, psychological
QoL improved after music-cued and non-cued MI, but
remained stable after music- and verbally-cued MI.
These results seem to contradict the acceptability re-
ports of participants, and probably could be associated
with the lowest baseline QoL in participants of the
MVMI group and their higher disability, as evidenced by
median EDSS scores of 4.5, when compared to 2.5 in the
other groups; however, these between-group differences
were not statistically significant.
Motor imagery ability
In accordance with the literature about the multifaceted
construct of MI, we used two different approaches to as-
sess the ability to imagine movements in participants, an
MI questionnaire and a mental chronometry test [9, 12].
MI ability testing showed that all participants seemed to
have been able to practice MI as indicated by median
KVIQ-G-10 values of 4.0 (interquartile range 3.2, 4.6)
out of 5.0. These scores imply adequate MI vividness
[55, 58] and are consistent with a study from Heremans
et al. (2012) in 30 people with MS who observed very
similar KVIQ-10 scores [13]. However, in the absence of
statistically significant group differences, participants in
the MVMI group had lower baseline kinaesthetic MI
scores than the other groups. The discrepancy in results
could be associated with their higher disability and fa-
tigue. Post-intervention, the greatest improvement in the
kinaesthetic MI ability was observed in the MVMI
group, so that their scores were comparable to the MMI
and MI groups. These improvements could be associated
with motor learning; motor performance curves typically
start with a slowly ascending slope, followed by a sharp
increase in performance improvement over a period of
practice [77]. In agreement with another study from
Heremans et al. (2012), who found that external cueing
significantly improved the MI quality in people with MS,
we suggest that the music- and verbal cueing enhanced
their kinaesthetic MI capability [17]. Starting from
higher baseline MI capabilities in the MMI group, a
smaller improvement was seen after the intervention. A
larger study is required to explore underlying
mechanisms.
On the TDMI screening test, the numbers of imagined
stepping movements of the left and right lower extrem-
ities were strongly related to the three different time pe-
riods of 15, 25 and 45 s, as evidenced by Spearman’s
correlations of median 0.78 (interquartile range 0.77,
0.84) to the three different time periods of 15, 25 and
45 s. These results are suggestive of high temporal con-
gruence of imagined stepping movements [12]. Our re-
sults appear to contradict findings from previous studies
that used different mental chronometry tests, related to
the upper extremities [13–15]. However, these authors
linked impaired MI in this population to cognitive
dysfunction [13, 15] and depression [14]. Therefore, we
did not include persons with cognitive impairment and/
or depression in our study. However, we did not use
formal testing for cognitive function and mood, by
which we could have obtained accurate results. Import-
antly, we do not intend to withhold the treatment from
people with MS and cognitive impairment or depression
in the main study, but it does not seem useful to recruit
patients into an MI intervention group when the litera-
ture has already demonstrated their diminished ability to
perform MI.
Reliability and repeatability
Evaluation of the 2D quantitative gait analysis system
showed excellent reliability and repeatability. This is a
substantial requirement to assess the degree of gait
synchronisation with music beat in the main study. Our
results are in line with work from Harris-Hayes et al.
(2014) who examined the reliability and validity of a 2D
video based quantitative gait analysis system, and found
substantial to excellent reliability between three raters,
in addition to excellent validity [62]. Similarly, Norris
and Olson (2011) analysed concurrent validity and
reliability of 2D video-based motion analysis of the knee
and hip joint movement [63]. Using an appropriate mo-
tion analysis software and goniometer measures for joint
angles, they found excellent concurrent validity. Their
reliability measures showed excellent intra- and inter-
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rater as well as intra-rater reliability. Recently, Paul et al.
(2016) assessed the validity and reliability of a 2D mo-
tion analysis instrument. They compared an established
and sophisticated 3D motion analysis system against a
2D motion analysis system including a commercially
available camera, both with the corresponding video
analysis software [78]. The authors found excellent
agreement between the 2D and 3D systems during bal-
ance testing, and excellent reliability of the 2D system.
In this study, we did not use reflective markers to better
identify specific body parts, because we were mainly inter-
ested in measuring initial contact or heel-strike points of
the gait cycle. Thanks to modern camcorder 4 K technol-
ogy and a well-lit hallway, excellent image exposure was
achieved, so reflective markers were redundant. Our sug-
gestions were supported by recent work from Castelli et al.
[79] who compared a 2D motion analysis in the sagittal
plane with and without markers [79]. They observed high
correlations between kinematic measures across different
gait speeds for all joints between the two techniques.
The results from our reliability study showed that the
gait analysis system was a reliable instrument with low
measurement errors related to step time data (SEM
0.014 s) and low to moderate measurement errors re-
lated to the step length data (SEM 0.013 m). Accord-
ingly, the MDC95 for the step time measures was 0.038 s
and 0.037 m for the step length measures. Comparable
research showed similar measurement errors for step
time (SEM 0.001–0.009 s) and step length (SEM 0.03–
0.07 m) measures while using a 2D video-based gait ana-
lysis in healthy people [80]. In agreement with this, a
further study, which investigated the SEM and MDC
using an electronic walkway, found measurement errors
for step time of 0.007 s in younger individuals and of
0.015 s in older people, respectively; the SEM for step
length was 0.006 m and 0.017 m in the same population.
The same study found a MDC of 0.019 s and 0.042 s for
step time and of 0.016 m and 0.047 m for step length for
younger and older people, respectively [81]. Consistent
with this, the above cited study from Paul et al. found
measurement errors of 0.024–0.064 s for step time and
of 0.001–0.015 m for step length, obtained from a 2D
gait analysis system versus a 3D system [78]. Our results
suggest that the music-cueing impacted on the partici-
pants’ gait as this was the only study which used music-
cueing, but this could not be substantiated. Overall, the
findings from the reliability study showed that the gait
analysis system can be used with confidence to measure
gait synchronisation with music beat in the main study.
Study limitations
Due to the small sample size, the results should be consi-
dered preliminary and not generalisable to a larger popu-
lation of individuals with MS. At the baseline, there was
no statistically significant imbalance between groups. The
female-to-male ratio indicated a probable selection bias,
most likely associated with the small sample size. Thirteen
females and two males were included in the study, which
represents a female-to-male ratio of 6.5:1 and does not
correspond to previously reported data from the UK with
2.4:1 [82] and Austria with 2.7:1 [83].
The lack of blinding is a relevant limitation of this study.
To minimise this limitation, a script was used by the
physiotherapist who gave the instructions and assessed
participants, and support was provided consistently. Apart
from the fact that blinding of the participants would not
have been feasible because they would have realised their
group allocation, so far, none of the interventions is
known to be superior to the others. Both walking tests
were performed according to internationally recognised
guidelines and instructions. Nonetheless, it is possible
that, even if not intentionally, the assessor might have
exerted an influence through her knowledge of group
allocation. Therefore, it is relevant to implement blinding
of the assessors in an eventual subsequent study.
Consequences for the main study
The results from this study suggest that a full-scale RCT
is feasible. Relevant requirements elaborated for the
main study are described as follows.
Randomisation
Considering the threat of selection bias, stratified ran-
domisation will be applied by an independent researcher
to balance groups. The stratification will be according to
relevant prognostic factors for a change in walking,
namely, age (< 40, ≥40), gender (female, male) and dis-
ability (EDSS: 1.5–3.0, 3.5–4.5) [84]. In our previous
study, we already used such a randomisation procedure
on a similar population [19].
Allocation concealment
To prevent allocation bias, allocation concealment
will be performed in the main study. As with this
feasibility study, each participant will be assigned a
unique identification number (ID). A computer gener-
ated randomisation list based on the predefined strata
will be generated by an independent researcher at the
Medical University of Innsbruck. Sealed opaque enve-
lopes including group allocation numbers 1, 2 and 3
will be created by the same researcher, which will be
stored in a sequentially numbered order based on the
randomisation list. These envelopes will be allocated
to each participant in the order in which they are
recruited. Participants will be asked to unseal the
envelopes themselves and not to discuss their group
allocation until study completion.
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Blinding
Involvement of three intervention groups in this feasibil-
ity study made it unlikely that the allocation to a certain
group influenced participant motivation, behaviour or
adherence. Compliance reports were similar in all
groups, and neither the participants nor the researchers
could know in advance which intervention, if any, might
induce greater improvements in performance. Once they
will be allocated to a treatment, participants will be
aware of the type of intervention. Concerning the asses-
sors, it is relevant to implement blinding in an eventual
subsequent study.
Assessments
During the participant selection procedure, a minimal
screening of hearing will be considered since a hearing
impairment could limit the participation in a (cued) MI
intervention. For the evaluation of participants’ cognitive
capacity and mood/depression, it seems useful to
consider standardised measurement tools such as the
Mini-Mental State Examination [85] and the Beck
Depression Inventory [86].
Reliability study
A further development of the reliability study will be
considered for a future study, using an extended sample
size and employing different assessors. Such a study
could be used to confirm intra-rater reliability values
and to examine test-retest reliability.
Conclusion
Results from our feasibility study demonstrated that a
full-scale RCT is feasible to investigate the mecha-
nisms of differently cued and non-cued MI interven-
tions and their effect on walking, fatigue and QoL in
people with MS. The gait analysis instruments were
found to be reliable and a future study could validate
these results. Stratified randomisation using a
computer-generated randomisation sequence and allo-
cation concealment should be used in the main study.
It is essential to implement blinding in a further
study. Additional assessments will be considered to
screen their hearing and evaluate their cognitive
function and potential depression.
The preliminary improvements in walking speed, walk-
ing distance, fatigue, QoL and MI ability in the three
groups are promising however need to be confirmed.
After a familiarisation with cued and non-cued MI, the
participants showed adequate MI ability, which could
have influenced these improvements. Results from the
ongoing main study shall be used to provide specific rec-
ommendations for clinically working physiotherapists on
the use of (cued) MI in people with MS.
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